DMAC
DiaMedica Therapeutics Inc.
There isn't enough reported data to score DMAC yet.
DMAC Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
DMAC's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
DMAC PE Valuation
DMAC has no meaningful PE right now: it lost money over the past year.
DMAC Forward outlook
There aren't enough analyst estimates for DMAC to show an outlook.
DMAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.78 | -$0.05 |
| Q2 2026 | -$0.74 | -$0.03 |
| Q1 2026 | -$0.73 | -$0.07 |
| Q4 2025 | -$0.72 | -$0.10 |
| Q3 2025 | -$0.73 | -$0.15 |
| Q2 2025 | -$0.71 | -$0.16 |
| Q1 2025 | -$0.66 | -$0.08 |
| Q4 2024 | -$0.62 | +$0.02 |
DMAC lost $0.78 per share over the past year, about the same as its loss the year before.
DMAC Quarterly Revenue
DMAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$8.8M | -$2.3M |
| Q2 2026 | -$8.1M | -$513K |
| Q1 2026 | -$9.1M | -$1.9M |
| Q4 2025 | -$7.8M | -$1.3M |
| Q3 2025 | -$6.6M | -$2.1M |
| Q2 2025 | -$7.6M | -$3.1M |
| Q1 2025 | -$7.2M | -$499K |
| Q4 2024 | -$6.4M | -$2.6M |
DMAC has burned cash in almost every quarter: −$34M over the past year, against −$28M the year before.
DMAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +49.2K shares |
| 1 year | +8.7% | +4.3M shares |
| 3 years | +42% | +16M shares |
| 5 years | +187% | +35.2M shares |
| Available history | +350% | +42M shares |
DMAC has 54M diluted shares, up 8.7% from a year ago.
DMAC Net Leverage
DMAC's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DMAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 66.8 | Neutral |
| Stochastic | 69.4 | Neutral |
DMAC's weekly RSI is 67 (neutral) and its Stochastic is 69 (neutral).
DMAC PE vs Healthcare Sector
DMAC has no meaningful PE right now: it lost money over the past year.
DMAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.59 | 8.6% above |
| 20 week MA | $7.54 | 24% above |
| 50 week MA | $7.35 | 27% above |
| 100 week MA | $6.36 | 47% above |
| 200 week MA | $4.66 | 100% above |
DMAC is in an uptrend: it's above all five of its weekly moving averages, and 100% above its 200-week average.
DMAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.92 | $9.64 | +96% |
| 2021 | $9.64 | $3.60 | -63% |
| 2022 | $3.60 | $1.55 | -57% |
| 2023 | $1.55 | $2.84 | +83% |
| 2024 | $2.84 | $5.41 | +90% |
| 2025 | $5.41 | $8.23 | +52% |
| 2026 YTD | $8.23 | $9.33 | +13% |
DMAC has finished higher in four of the last six years, four of them by more than 50%. It's up 13% so far in 2026.